WILSON TROY EDWARD sold RNA
August 6, 2025 · Form 4 insider transaction
WILSON TROY EDWARD sold 17,777 shares of Atrium Therapeutics, Inc. at $45.00 per share, a transaction worth $800.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
17,777
Price
$45.00
Total value
$800.0K
InsiderWILSON TROY EDWARD
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 6, 2025
Filing dateAugust 8, 2025
Shares owned after17,776
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.